Concise review: Fragile X proteins in stem cell maintenance and differentiation

Stem Cells

Volumn 32, Issue 7, 2014, Pages 1724-1733

  Li, Yue ^a   Zhao, Xinyu ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adult stem cells; Developmental biology; FMRP; Fragile X syndrome; Nervous system; Neural differentiation; Neural stem cell; Pluripotent stem cells; Stem cell plasticity

Indexed keywords

ARGONAUTE 2 PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; FMR1 PROTEIN, HUMAN; FXR1 PROTEIN, HUMAN; FXR2 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ASYMMETRIC CELL DIVISION; AUDIOGENIC SEIZURE; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL LINEAGE; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; CYTOPLASM; DENDRITIC SPINE; FRAGILE X SYNDROME; GENE EXPRESSION; GENE REGULATORY NETWORK; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; LATERAL BRAIN VENTRICLE; LEARNING; LEARNING DISORDER; LIFELONG LEARNING; LONG TERM DEPRESSION; MENTAL CAPACITY; MORPHOGENESIS; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOLAR LOCALIZATION SIGNAL; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; STEM CELL; SUBVENTRICULAR ZONE; ANIMAL; CHEMISTRY; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HUMANS; MUTATION; NEURAL STEM CELLS; RNA-BINDING PROTEINS;

EID: 84902593066     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1698     Document Type: Review

References (98)

1. Wang T, Bray SM, Warren ST,. New perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev 2012; 22: 256-263.
2. Deng W, Aimone JB, Gage FH,. Adult hippocampal neurogenesis, synaptic plasticity and memory: Facts and hypotheses. Nat Rev Neurosci 2010; 11: 339-350.
3. Hagerman PJ, Hagerman RJ,. The fragile-X premutation: A maturing perspective. Am J Hum Genet 2004; 74: 805-816.
4. Tassone F, Hagerman PJ,. Expression of the FMR1 gene. Cytogenet Genome Res 2003; 100: 124-128.
5. Darnell JC, Fraser CE, Mostovetsky O, et al. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 2005; 19: 903-918.
6. Sung YJ, Conti J, Currie JR, et al. RNAs that interact with the Fragile X syndrome RNA binding protein FMRP. Biochem Biophys Res Commun 2000; 275: 973-980.
7. Ascano M, Jr., Mukherjee N, Bandaru P, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 2012; 492: 382-386.
8. Reeve SP, Lin XD, Sahin HB, et al. Mutational analysis establishes a critical role for the N terminus of fragile X mental retardation protein FMRP. J Neurosci 2008; 28: 3221-3226.
9. Brown V, Jin P, Ceman S, et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001; 107: 477-487.
10. Darnell JC, Van Driesche SJ, Zhang CL, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011; 146: 247-261.
11. Ceman S, O'Donnell WT, Reed M, et al. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet 2003; 12: 3295-3305.
12. Narayanan U, Nalavadi V, Nakamoto M, et al. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 2007; 27: 14349-14357.
13. Cheever A, Ceman S,. Phosphorylation of FMRP inhibits association with Dicer. RNA 2009; 15: 362-366.
14. Muddashetty RS, Nalavadi VC, Gross C, et al. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell 2011; 42: 673-688.
15. Darnell JC, Fraser CE, Mostovetsky O, et al. Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs. Hum Mol Genet 2009; 18: 3164-3177.
16. Siomi MC, Siomi H, Sauer WH, et al. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J 1995; 14: 2401-2408.
17. Mientjes EJ, Willemsen R, Kirkpatrick LL, et al. Fxr1 knockout mice show a striated muscle phenotype: Implications for Fxr1p function in vivo. Hum Mol Genet 2004; 13: 1291-1302.
18. Engels B, van't Padje S, Blonden L, et al. Characterization of Fxr1 in Danio rerio; a simple vertebrate model to study costamere development. J Exp Biol 2004; 207: 3329-3338.
19. Siomi MC, Zhang Y, Siomi H, et al. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Molecular and Cellular Biology 1996; 16: 3825-3832.
20. Zhang J, Fang Z, Jud C, et al. Fragile X-related proteins regulate mammalian circadian behavioral rhythms. Am J Hum Genet 2008; 83: 43-52.
21. Say E, Tay HG, Zhao ZS, et al. A functional requirement for PAK1 binding to the KH(2) domain of the fragile X protein-related FXR1. Mol Cell 2010; 38: 236-249.
22. Bontekoe CJ, McIlwain KL, Nieuwenhuizen IM, et al. Knockout mouse model for Fxr2: A model for mental retardation. Hum Mol Genet 2002; 11: 487-498.
23. Christie SB, Akins MR, Schwob JE, et al. The FXG: A presynaptic fragile X granule expressed in a subset of developing brain circuits. J Neurosci 2009; 29: 1514-1524.
24. Akins MR, Leblanc HF, Stackpole EE, et al. Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions. J Comp Neurol 2012; 520: 3687-3706.
25. Zhang J, Hou L, Klann E, et al. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. J Neurophysiol 2009; 101: 2572-2580.
26. Napoli I, Mercaldo V, Boyl PP, et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 2008; 134: 1042-1054.
27. Caudy AA, Myers M, Hannon GJ, et al. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 2002; 16: 2491-2496.
28. Ishizuka A, Siomi MC, Siomi H,. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 2002; 16: 2497-2508.
29. Plante I, Davidovic L, Ouellet DL, et al. Dicer-derived MicroRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs. J Biomed Biotechnol 2006; 2006: 64347-64358.
30. Jin P, Zarnescu DC, Ceman S, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 2004; 7: 113-117.
31. Edbauer D, Neilson JR, Foster KA, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010; 65: 373-384.
32. McCaffery P, Deutsch CK,. Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol 2005; 77: 38-56.
33. Davidovic L, Bechara E, Gravel M, et al. The nuclear MicroSpherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons. Hum Mol Genet 2006; 15: 1525-1538.
34. Davidovic L, Jaglin XH, Lepagnol-Bestel AM, et al. The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum Mol Genet 2007; 16: 3047-3058.
35. El Fatimy R, Tremblay S, Dury AY, et al. Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected]. PLoS One 2012; 7: e39338.
36. Dictenberg JB, Antar LN, Singer RH, et al. A direct role for FMRP in activity dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 2008; 14: 926-939.
37. Antar LN, Li CX, Zhang HL, et al. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci 2006; 32: 37-48.
38. Bear M,. The mGluR theory of fragile X mental retardation. Trends Neurosci 2004; 27: 370-377.
39. Smrt RD, Zhao X,. Epigenetic regulation of neuronal dendrite and dendritic spine development. Front Biol 2010; 5: 304-323.
40. Zalfa F, Eleuteri B, Dickson KS, et al. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 2007; 10: 578-587.
41. Zhang MQ, Wang QQ, Huang YQ,. Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells. Proc Natl Acad Sci USA 2007; 104: 10057-10062.
42. Wang W, Zhu JZ, Chang KT, et al. DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis. EMBO J 2012; 31: 3655-3666.
43. Guo W, Murthy AC, Zhang L, et al. Inhibition of GSK3beta improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome. Hum Mol Genet 2012; 21: 681-691.
44. Min WW, Yuskaitis CJ, Yan QJ, et al. Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential. Neuropharmacology 2009; 56: 463-472.
45. Gross C, Nakamoto M, Yao XD, et al. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 2010; 30: 10624-10638.
46. Fatemi SH, Folsom TD, Kneeland RE, et al. Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase, and homer 1, in autism: A postmortem study in cerebellar vermis and superior frontal cortex. Mol Autism 2013; 4: 21-39.
47. Lohith TG, Osterweil EK, Fujita M, et al. Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome? Mol Autism 2013; 4: 15-22.
48. Weng N, Weiler IJ, Sumis A, et al. Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet Part B-Neuropsychiatr Genet 2008; 147B: 1253-1257.
49. Sharma A, Hoeffer CA, Takayasu Y, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 2010; 30: 694-702.
50. Michalon A, Sidorov M, Ballard TM, et al. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 2012; 74: 49-56.
51. Huber KM, Roder JC, Bear MF,. Chemical induction of mGluR5- and protein synthesis-Dependent long-term depression in hippocampal area CA1. J Neurophysiol 2001; 86: 321-325.
52. Min WW, Yuskaitis CJ, Yan Q, et al. Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential. Neuropharmacology 2009; 56: 463-472.
53. Yuskaitis CJ, Mines MA, King MK, et al. Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome. Biochem Pharmacol 2010; 79: 632-646.
54. King MK, Jope RS,. Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. Genes Brain Behavior 2013; 12: 723-731.
55. Gross C, Bassell GJ,. Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110 beta-selective inhibitor. Mol Med 2012; 18: 336-345.
56. Li X, Zhao X,. Epigenetic regulation of mammalian stem cells. Stem Cells Dev 2008; 17: 1043-1052.
57. Jobe EM, McQuate AL, Zhao X,. Crosstalk among epigenetic pathways regulates neurogenesis. Front Neurosci 2012; 6: 59-73.
58. Callan MA, Zarnescu DC,. Heads-up: New roles for the fragile X mental retardation protein in neural stem and progenitor cells. Genesis 2011; 49: 424-440.
59. Yang LL, Duan RH, Chen DS, et al. Fragile X mental retardation protein modulates the fate of germline stem cells in Drosophila. Hum Mol Genet 2007; 16: 1814-1820.
60. Yang YY, Xu SL, Xia LX, et al. The bantam microRNA is associated with drosophila fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genet 2009; 5: e1000444.
61. Epstein AM, Bauer CR, Ho A, et al. Drosophila fragile X protein controls cellular proliferation by regulating cbl levels in the ovary. Dev Biol 2009; 330: 83-92.
62. Reich J, Papoulas O,. Caprin controls follicle stem cell fate in the Drosophila ovary. PLoS One 2012; 7: e35365.
63. Castren M, Tervonen T, Karkkainen V, et al. Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci USA 2005; 102: 17834-17839.
64. Bhattacharyya A, McMillan E, Wallace K, et al. Normal neurogenesis but abnormal gene expression in human fragile X cortical progenitor cells. Stem Cells Dev 2008; 17: 107-117.
65. Tervonen TA, Louhivuori V, Sun X, et al. Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis 2009; 33: 250-259.
66. Saffary R, Xie ZG,. FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development. J Neurosci 2011; 31: 1427-1439.
67. Callan MA, Cabernard C, Heck J, et al. Fragile X protein controls neural stem cell proliferation in the Drosophila brain. Hum Mol Genet 2010; 19: 3068-3079.
68. Luo Y, Shan G, Guo W, et al. Fragile X mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet 2010; 6: e1000898.
69. Eiges R, Urbach A, Malcov M, et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007; 1: 568-577.
70. Telias M, Segal M, Ben-Yosef D,. Neural differentiation of Fragile X human embryonic stem cells reveals abnormal patterns of development despite successful neurogenesis. Dev Biol 2013; 374: 32-45.
71. Sheridan SD, Theriault KM, Reis SA, et al. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 2011; 6: e26203.
72. Liu J, Koscielska KA, Cao Z, et al. Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet 2012; 21: 3795-3805.
73. Spradling A, Fuller MT, Braun RE, et al. Germline stem cells. Cold Spring Harb Perspect Biol 2011; 3: a002642.
74. Costa A, Wang Y, Dockendorff TC, et al. The Drosophila fragile X protein functions as a negative regulator in the orb autoregulatory pathway. Dev Cell 2005; 8: 331-342.
75. Pepper AS, Beerman RW, Bhogal B, et al. Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects. PLoS One 2009; 4: e7618.
76. Slegtenhorst-Eegdeman KE, de Rooij DG, Verhoef-Post M, et al. Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development. Endocrinology 1998; 139: 156-162.
77. Oatley MJ, Racicot KE, Oatley JM,. Sertoli cells dictate spermatogonial stem cell niches in the mouse testis. Biology of reproduction 2011; 84: 639-645.
78. Kriegstein A, Alvarez-Buylla A,. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 2009; 32: 149-184.
79. Louhivuori V, Vicario A, Uutela M, et al. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol Dis 2011; 41: 469-480.
80. Zang JB, Nosyreva ED, Spencer CM, et al. A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet 2009; 5: e1000758.
81. Bagni C, Tassone F, Neri G, et al. Fragile X syndrome: Causes, diagnosis, mechanisms, and therapeutics. J Clin Invest 2012; 122: 4314-4322.
82. Eadie BD, Zhang WN, Boehme F, et al. Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus. Neurobiol Dis 2009; 36: 361-373.
83. Guo WX, Allan AM, Zong RT, et al. Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning. Nat Med 2011; 17: 559-565.
84. Callan MA, Clements N, Ahrendt N, et al. Fragile X protein is required for inhibition of insulin signaling and regulates glial-dependent neuroblast reactivation in the developing brain. Brain Res 2012; 1462: 151-161.
85. Guo W, Zhang L, Christopher DM, et al. RNA-binding protein FXR2 regulates adult hippocampal neurogenesis by reducing Noggin expression. Neuron 2011; 70: 924-938.
86. Evans MJ, Kaufman MH,. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-156.
87. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
88. Ren J, Jin P, Wang E, et al. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 2009; 7: 20-36.
89. Dvash T, Ben-Yosef D, Eiges R,. Human embryonic stem cells as a powerful tool for studying human embryogenesis. Pediatr Res 2006; 60: 111-117.
90. Gerhardt J, Tomishima MJ, Zaninovic N, et al. The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells. Mol Cell 2014; 53: 19-31.
91. Urbach A, Bar-Nur O, Daley GQ, et al. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010; 6: 407-411.
92. Gafni O, Weinberger L, Mansour AA, et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 2013; 504: 282-286.
93. Berry-Kravis E, Potanos K,. Psychopharmacology in fragile X syndrome-present and future. Ment Retard Dev Disabil Res Rev 2004; 10: 42-48.
94. Paribello C, Tao L, Folino A, et al. Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol 2010; 10: 91-99.
95. Olmos-Serrano JL, Corbin JG, Burns MP,. The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev Neurosci 2011; 33: 395-403.
96. Xu ZH, Yang Q, Feng B, et al. Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome. Mol Neurodegener 2012; 7: 24-37.
97. Liu ZH, Huang TJ, Smith CB,. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome. Neurobiol Dis 2012; 45: 1145-1152.
98. Pacey LK, Doering LC,. Developmental expression of FMRP in the astrocyte lineage: Implications for fragile X syndrome. Glia 2007; 55: 1601-1609.